4.80
-0.23 (-4.57%)
-0.23 (-4.57%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.23 | -4.57% | 4.80 | 09:04:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.03 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.80 | 4.81 | 0.01 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 37 | 3,045 | 389,901 | 1.27 - 5.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:04:27 | formt | 325 | $ 4.80 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 62.22M | 13.02M | 6.45M | $ 1.11M | $ - | -0.23 | -19.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.81 | 5.88 | 3.8099 | 4.44 | 607,883 | 0.99 | 25.98% |
| 1 Month | 3.51 | 5.88 | 3.37 | 4.06 | 349,567 | 1.29 | 36.75% |
| 3 Months | 2.88 | 5.88 | 2.71 | 3.52 | 319,200 | 1.92 | 66.67% |
| 6 Months | 2.60 | 5.88 | 1.62 | 3.13 | 1,471,870 | 2.20 | 84.62% |
| 1 Year | 3.11 | 5.88 | 1.27 | 3.28 | 1,351,294 | 1.69 | 54.34% |
| 3 Years | 3.67 | 5.88 | 0.50 | 3.23 | 471,771 | 1.13 | 30.79% |
| 5 Years | 3.85 | 5.88 | 0.50 | 3.44 | 364,446 | 0.95 | 24.68% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
